Background. Rapid right ventricular pacing (RRVP) at 250 bpm for 3-6 weeks produces chronic heart failure manifested by a reduction in cardiac output and increases in right atrial, pulmonary artery, and capillary wedge pressures.
C hronic rapid right ventricular pacing (RRVP) produces severe heart failure in dogs characterized by a low cardiac output and abnormal systolic and diastolic left ventricular function with increased right and left heart filling pressures.'-" Although a great deal is known about some of the mechanisms involved in the production of heart failure by RRVP, including the development of myocardial substrate depletion without left ventricular hypertrophy or myocardial ischemia, peripheral manifestations have not been well studied.
Alterations in skeletal muscle perfusion in vivo'2 and peripheral and coronary artery responsiveness to a-adrenoceptor agonists and nitroglycerin in vitro13-17 have been reported, but there have been no investigations of total vascular capacitance or compliance in animals with heart failure induced by RRVP. The neuroendocrine response with the development of failure is profound and closely resembles that observed in patients. Since heart failure is also characterized by alterations in total vascular capacitance and compliance as well as distribution of the circulating volume, we embarked on a study of the effects of chronic RRVP on these parameters.
Methods
Nineteen conditioned dogs free of heartworms and parasites and weighing 18-25 kg (mean, 23 kg) premedicated with acepromazine (0.5 mg . kg-') were anesthetized with isoflurane and subjected to a splenectomy through a midline abdominal incision. A unipolar pacemaker lead was advanced through the external jugular vein to the right ventricle under electrocardiographic control and a programmable pulse generator (SX 5940, Medtronic, Richmond, B.C., Canada) was placed in a subcutaneous pocket between the scapulae with the pulse set at 60 bpm. The animals underwent a baseline study [7] [8] [9] [10] days after surgery. Subsequently, nine animals were used as sham controls with the pacemaker continuing at 60 bpm for 4 weeks before a second study, and 10 underwent chronic rapid right ventricular pacing (RRVP) at 250 bpm for 6 weeks or until severe heart failure had developed as indicated by rapid weight gain, ascites, or marked respiratory distress. The animals were scheduled to be restudied at approximately 3 and 6 weeks of chronic pacing. The pulse generator was then reset to 60 beats per minute and the animals restudied after 1 and 2 weeks of recovery.
For each study, the fasting animal was premedicated with acepromazine (0.5 mg* kg`i.m.) and lightly anesthetized with sodium pentobarbital (12 mg* kg`1 i.v. AV/APmcf where AV is the change in total circulating volume in milliliters per kilogram.
Arterial compliance (ml * mm Hg`1 kg-1):
where T is the time constant in minutes derived from the arterial pressure decay curve following the last beat after acetylcholine infusion.21
Arterial bed volume transfer (ml * kg-1) was calculated from the differences in arterial capacity (arterial compliance) multiplied by Psa between each experimental condition.
Central blood volume (pulmonary artery to aortic root) (ml * kg-1):
MTT CO CBV= 60
where MTT is mean transit time in seconds between the distal pulmonary artery and aortic root using the Stewart Hamilton technique and separately measured CO by thermal dilution (right atrium to pulmonary artery). We assumed that the loss of thermal indicator in the lungs and the heart was proportionately the same in all pathways. Effective pulmonary (central) vascular compliance was estimated from the plot of Ppcw against CBV at baseline blood volume and after the 10-ml * kg-' increase in circulating volume using the inverse of the slope of the Ppcw/CBV relation.22 Unstressed central vascular volume was estimated from the volume intercept when Ppcw was 0.
Stressed vascular volume (ml * kg-')=Pmcfxtotal vascular compliance.
Unstressed vascular volume (Vo) (ml * kg-')= TBV-stressed vascular volume.
Total vascular compliance was calculated by determining Pmcf at baseline blood volume and after increasing circulating volume by 5 and 10 ml * kg-'. All values are reported as mean+SEM. Paired Student's t tests or ANOVA was used to examine changes, with a level ofp<0.05 considered statistically significant. The protocol was approved by the Animal Care Committee of The Toronto Hospital (Western Division).
Results
The nine control animals were restudied 30.5±+1.2 days after the baseline study. Of the 10 animals chronically paced at 250 beats per minute, three were not studied at midpoint (early failure), two died suddenly in late failure after the early failure study, and one animal died in the early recovery period after pacing had been terminated. Thus, seven animals were studied in early failure (23.1+8.1 days), seven in failure (38.3+±8.4 days), and seven animals during recovery at 1 and 2 weeks after stopping pacing at 250 beats per minute.
Hemodynamic Alterations
The nine control animals exhibited no significant alterations in hemodynamics after 30.5 days. The animals subjected to RRVP slight but variable reductions in Psa, marked reduction in CO during failure with improvement during recovery (Figure 1 ). Total Vascular Capacitance and Compliance TBV, Pmcf, unstressed and stressed vascular volumes, and total vascular compliance were unaltered after 30.5 days in the control animals ( Figure 2 ). In the animals subjected to chronic RRVP at 250 bpm, Pmcf increased while total blood volume was reduced with the development of heart failure so that the pressure-volume relation was shifted leftward (Figure 3 ). With recovery after pacing, the pressure-volume relation was shifted rightward toward baseline with a reduction in Pmcf and increase in blood volume (Figure 4) .
Total vascular compliance was slightly but insignificantly reduced with failure, 2.08±0.28 versus 2.58±0.28 ml * mm Hg`1 kg`at baseline, and increased to 3.6±0.37 ml mmHg`. kg`at 2 weeks of recovery ( Figure 5 ). Unstressed vascular volume decreased and stressed volume increased with the development of failure ( Figure 6 ). Total vascular capacitance at a theoretically constant Pmcf of 6 mm Hg was reduced from 97.4± 6.3 ml * kg`at baseline to 59.9 ±9.9 ml * kg-1 with failure (p<0.01) with recovery by 2 weeks postpacing to 86.1±5.1 ml * kg-'. TBV was decreased mainly due to a reduction in packed cell volume, which measured 46.9±1.7%, 39 .9±2.3%, 36.3±2.0%, and 39.6±1.5% at baseline, early failure, failure, and 2 weeks recovery, respectively. Arterial compliance was reduced (0.066±0.008 to 0.033±0.007 ml mmHg-.kg-') with failure but returned to baseline values at 2 weeks after pacing. As a consequence, arterial capacity was reduced (6.1±0.8 to 2.6±0.6 ml * kg-') with failure with some recovery by 2 weeks after pacing (4.6±0.6 ml * kg-'). The reduction in arterial capacity and total vascular capacitance with the development of heart failure was associated with a significant increase in CBV (Figure 7) . By 2 weeks after pacing, CBV as a proportion of TBV had returned to baseline values.
Effective pulmonary (central) vascular compliance was reduced with the development of failure (Figure 8 ). Thus, failure was associated with a reduction of central vascular capacitance largely due to a reduction in central vascular compliance. In the 2-week postpacing period the compliance of this bed was increased toward baseline values. Discussion This is the first demonstration that the development of heart failure with chronic RRVP was associated with a profound reduction in total vascular capacitance (Figure 3) . The increased from 8.6±0.5 to 9.5±0.9 ml * kg`. However, the increase in CBV as a proportion of TBV was significant ( Figure 7 ). Effective pulmonary (central) vascular compliance was also altered during failure as Ppcw increased more than expected as compared to the baseline relationship of Ppcw and CBV. Total vascular capacitance is largely composed of venous capacitance as arterial capacity is such a small portion of the total (6.1±0.8 versus 97.4 ml. kg-1 at baseline). Total vascular compliance also largely reflects venous compliance as the latter is considerably greater than arterial compliance (2.58 ±0.28 versus 0.066±0.008 ml * mm Hg`1 . kg`at baseline). Although total vascular compliance was not significantly reduced with the development of failure, systemic arterial and pulmonary vascular compliance were both reduced. The reduction in systemic arterial compliance resulted in a reduction in arterial capacity and a net transfer of blood volume from arteries to veins. The reduction in pulmonary vascular compliance resulted in a higher pulmonary capillary wedge pressure for any given CBV than observed at baseline studies or in sham dogs.
These dogs underwent rapid recovery in the 2-week postpacing period. Only minimal reductions in CO and the CO response to volume loading remained along with TOTAL BLOOD VOLUME mlIkg-FIGURE 6. Unstressed and stressed blood volume (upper graph), total blood and plasma volume (lower graph), at baseline, after 23.1+8.1 and 38.3±8.4 days of rapid right ventricularpacing at 250 bpm, and 1 and 2 weeks ofrecovery after pacing. With the development of failure, unstressed volume and total blood volume were reduced, while stressed volume was increased.
a nonsignificant reduction in TBV and unstressed volume, plus an increase in total vascular compliance causing a lower Pmcf. The mechanism causing the marked reduction in total vascular capacitance due to a reduction in unstressed volume cannot be determined from these experiments. Active contraction of vascular beds without altering vascular compliance must have occurred as Pmcf was increased without altering the Pmcf-TBV relation. Some passive recoil of vascular beds as TBV diminished is also possible, but because Pmcf was increased, active contraction must have occurred. We speculate that the neuroendocrine response to RRVP and the development of heart failure is responsible for both the reduction in total vascular capacitance and the reduction in TBV.
The neuroendocrine response to RRVP and the development of heart failure is striking. CENTRAL BLOOD VOLUME mI.kg-1 
